HealthSouth Corporation (NYSE:HLS) CEO Sells $972,875.00 in Stock
HealthSouth Corporation (NYSE:HLS) CEO Mark J. Tarr sold 22,625 shares of the firm’s stock in a transaction dated Monday, August 7th. The stock was sold at an average price of $43.00, for a total transaction of $972,875.00. Following the completion of the sale, the chief executive officer now directly owns 283,134 shares of the company’s stock, valued at $12,174,762. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.
Shares of HealthSouth Corporation (NYSE HLS) opened at 43.68 on Wednesday. The firm’s 50-day moving average is $46.14 and its 200-day moving average is $44.07. HealthSouth Corporation has a 1-year low of $36.97 and a 1-year high of $49.71. The company has a market capitalization of $3.94 billion, a price-to-earnings ratio of 15.92 and a beta of 0.61.
HealthSouth Corporation (NYSE:HLS) last announced its quarterly earnings data on Monday, July 31st. The company reported $0.71 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.68 by $0.03. The firm had revenue of $981.30 million during the quarter, compared to analyst estimates of $976.46 million. HealthSouth Corporation had a net margin of 6.70% and a return on equity of 25.07%. HealthSouth Corporation’s revenue was up 6.6% on a year-over-year basis. During the same period last year, the firm posted $0.69 EPS. Analysts forecast that HealthSouth Corporation will post $2.71 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Monday, October 2nd will be given a $0.25 dividend. This is a positive change from HealthSouth Corporation’s previous quarterly dividend of $0.24. This represents a $1.00 annualized dividend and a dividend yield of 2.29%. The ex-dividend date is Friday, September 29th. HealthSouth Corporation’s dividend payout ratio (DPR) is presently 35.29%.
WARNING: “HealthSouth Corporation (NYSE:HLS) CEO Sells $972,875.00 in Stock” was first reported by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another website, it was copied illegally and reposted in violation of international copyright legislation. The original version of this article can be read at https://www.dailypolitical.com/2017/08/09/healthsouth-corporation-nysehls-ceo-sells-972875-00-in-stock.html.
Institutional investors have recently modified their holdings of the company. State of Alaska Department of Revenue acquired a new position in shares of HealthSouth Corporation during the first quarter valued at $235,000. Legato Capital Management LLC increased its position in shares of HealthSouth Corporation by 5,612.1% in the first quarter. Legato Capital Management LLC now owns 59,806 shares of the company’s stock valued at $1,397,000 after buying an additional 58,759 shares during the period. Louisiana State Employees Retirement System increased its position in shares of HealthSouth Corporation by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 22,500 shares of the company’s stock valued at $963,000 after buying an additional 300 shares during the period. CWM LLC increased its position in shares of HealthSouth Corporation by 2.1% in the first quarter. CWM LLC now owns 6,384 shares of the company’s stock valued at $273,000 after buying an additional 130 shares during the period. Finally, Americafirst Capital Management LLC increased its position in shares of HealthSouth Corporation by 124.8% in the first quarter. Americafirst Capital Management LLC now owns 16,349 shares of the company’s stock valued at $700,000 after buying an additional 9,076 shares during the period. Institutional investors own 97.96% of the company’s stock.
A number of brokerages recently issued reports on HLS. Zacks Investment Research raised shares of HealthSouth Corporation from a “hold” rating to a “buy” rating and set a $49.00 price target for the company in a research report on Wednesday, August 2nd. Piper Jaffray Companies reissued a “hold” rating and set a $50.00 price target on shares of HealthSouth Corporation in a research report on Thursday, August 3rd. Mizuho lifted their price target on shares of HealthSouth Corporation from $44.00 to $47.00 and gave the company a “neutral” rating in a research report on Monday, July 10th. Royal Bank Of Canada reissued a “buy” rating and set a $53.00 price target on shares of HealthSouth Corporation in a research report on Wednesday, July 5th. Finally, ValuEngine raised shares of HealthSouth Corporation from a “hold” rating to a “buy” rating in a research report on Friday, July 7th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and seven have assigned a buy rating to the stock. HealthSouth Corporation presently has an average rating of “Hold” and a consensus price target of $48.83.
HealthSouth Corporation Company Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.
Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.